Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Structure-Directed Expansion of Biphenyl-Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Potency and Safety — Limin Zhao (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Structure-Directed Expansion of Biphenyl-Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Potency and Safety
Shared by
De Clercq Erik
KU Leuven
Structure-Directed Expansion of Biphenyl-Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Potency and Safety
Article
2022
en
Authors
+2 more
LZ
Limin Zhao
CP
Christophe Pannecouque
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Structure-directed expansion of biphenyl-pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with significantly improved potency and safety
Limin Zhao
,
Christophe Pannecouque
,
De Clercq Erik
,
Shuai Wang
,
Fen‐Er Chen
Article
2022
Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability
Limin Zhao
,
Shuai Wang
,
Christophe Pannecouque
,
De Clercq Erik
,
Hu‐Ri Piao
,
Fen‐Er Chen
Article
2023
Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy
Ya-Li Sang
,
Christophe Pannecouque
,
De Clercq Erik
,
Shuai Wang
,
Fen‐Er Chen
Article
2022
Development of novel S-N3-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivity
Ling Xu
,
Qingqing Hao
,
Wenjuan Huang
,
Christophe Pannecouque
,
De Clercq Erik
,
Shuai Wang
,
Fen‐Er Chen
Article
2022
Development of Novel S-N3-DABOs Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Selectivity
Ling Xu
,
Qingqing Hao
,
Wenjuan Huang
,
Christophe Pannecouque
,
De Clercq Erik
,
Shuai Wang
,
Fen Er Chen
Discussion(0)
No comments yet. Be the first to comment.